Immunization against Network-pox
Unicamp has been plagued by a persistent, annual outbreak of a highly contagious but rarely fatal disease called Network-pox . Network-pox is an SIS-like pathogen (Susceptible-Infected-Susceptible) in which recovery from symptoms (a dangerous aversion to studying network science) confers only temporary immunity, so students quickly become susceptible again. The typical university population forms a highly heterogeneous contact network, where some students attend every lecture, participate in multiple clubs, forming large hubs, but others occasionally attend classes, study in their rooms, and have limited social interaction. Thankfully, Prof. Meidanis has found a cure for the Network-pox, the MO412 Vaccine, leading to a mass vaccination program, successfully immunizing 92% of the students at Unicamp at random. However, the question of whether the disease has been eradicated remains unsolved. A previous study has revealed that the Unicamp network was scale-free, with...